- Your selection
- Clear all
- Biotechnology x
- With Female Protagonist x
4 case(s) found.
New technological developments in biotechnology are creating new opportunities for less centralized production and distribution of biological medicines, including vaccines. This case explores how innovative small-scale production technologies in biotech enable more flexible production of vaccines and other biologic medicines in low- or middle-income countries (LMICs) and neighboring countries.
Reference 6850
Published 26 Jan 2024
Length 19 page(s)
Topic Operations
Region Africa
Industry Biotechnology
New technological developments in biotechnology are creating new opportunities for less centralized production and distribution of biological medicines, including vaccines. This case explores how innovative small-scale production technologies in biotech enable more flexible production of vaccines and other biologic medicines in low- or middle-income countries (LMICs) and neighboring countries.
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Reference 6684
Published 15 Nov 2021
Length 4 page(s)
Region Europe
Industry Biotechnology
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Reference 6684
Published 15 Nov 2021
Length 2 page(s)
Industry Biotechnology
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.
Reference 6684
Published 15 Nov 2021
Length 2 page(s)
Region Europe
Industry Biotechnology
Kusha Ahmad is tasked with facilitating headcount reduction following the acquisition of the Societe Francaise de Biotechnologie (SFB) by Big American Pharmaceuticals (BAP), and the subsequent closure of the SFB office in Lyon, France. In accordance with regulations introduced in 2017, staff are entitled to a “rupture conventionnelle collective”.